184
Participants
Start Date
February 28, 2005
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
lenalidomide
Two 5 mg capsules taken one time per day
Placebo
Two placebo capsules taken one time per day
Hospital for Joint Disease, New York
University of Rochester Medical Center, Rochester
Lehigh Valley Hospital, Allentown
Knobler Institute of Neurologic Disease, Fort Washington
Drexel University College of Medicine Department of Neurology Rm 7102, Philadelphia
Johns Hopkins Hospital, Baltimore
University of Virginia Pain Management Center, Charlottesville
Carolinas Pain Institute, P.A. & the Center for Clinical Research, LLC, Winston-Salem
Duke University Medical Center, Durham
Womack Army Medical Center, Fort Bragg
Space Coast Neurology, Palm Bay
Research Institute of Greater Dayton, Dayton
University of Iowa, Iowa City
Mayo Clinic, Rochester
Rehab Institute of Chicago, Chicago
Washington University Pain Mgmt Ctr, St Louis
University of Texas Southwestern Medical Center, Dallas
Texas Tech Medical Center Department of Anesthesiology, Lubbock
Pivotal Research Centers, Peoria
UCSD Center for Pain and Palliative Medicine, La Jolla
Loma Linda Institution, Loma Linda
Oregon Health & Science University, Portland
Swedish Pain Services, Seattle
Northwestern University, Chicago
Beth Israel Deaconess Medical Center, Boston
Baystate Medical Center, Springfield
UNC Hospitals University of North Carolina, Chapel Hill
Lead Sponsor
Celgene Corporation
INDUSTRY